MEDPMedpace Holdings, Inc.

$669.27+28% 1Y
Latest close: a new 52-week highOct 23, 2026what changed →

Is it growing?

Good

Growing: revenue growing +20% year on year and earnings up +26% year on year.

2 good, 1 neutral
Revenue trend+20% in a year

Trailing-twelve-month revenue vs a year earlier, from the company's own filings. Five-year pace: +21% a year.

Earnings trend+26% in a year

Trailing-twelve-month earnings per share against a year earlier. Growing faster than revenue, so margins or the share count are helping.

Margin direction−0.1 points operating

Trailing-twelve-month operating margin, 21.4% now against 21.5% a year earlier.

All from SEC EDGAR, as of Sep 30, 2026.

Against the whole market›

Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.

Revenue growth, 3 yearsbetter than 84% of the market

Where this answer is blind. These are trailing numbers from the filings, not forecasts: an acquisition or a one-off year can flatter them, so check the quarters.

Is MEDP growing?

Medpace Holdings, Inc.'s revenue has grown 17% a year over three years, and grown 21% a year over five, with earnings per share compounding at 28%.

+17%

Revenue growth, 3-year annual rate · Diagnostics & Research median +8.6% · compounding fast · compounded from trailing twelve-month revenue

Revenue growth, 5-year rate
+21%

Revenue growth, 5-year rate · +17% over three · growth has slowed since the five-year average

Earnings per share, 3-year rate
+28%

Earnings per share, 3-year rate · revenue +17% · earnings outgrew revenue: margins or the share count worked for shareholders

Years of annual history on file
11

Years of annual history on file · FY2015 to FY2025, as filed

Details›
Revenue FY2021
$1.14B
Revenue FY2022
$1.46B
Revenue FY2023
$1.89B
Revenue FY2024
$2.11B
Revenue FY2025
$2.53B

Annual income statements as filed with the SEC.